coronavirus
cov
vertebr
pathogen
caus
sever
diseas
wide
rang
anim
infect
human
recent
limit
common
cold
nevertheless
end
novel
coronaviru
caus
sever
acut
respiratori
syndrom
sarscov
emerg
china
rapidli
spread
worldwid
caus
around
infect
lead
death
case
sinc
cov
surveil
program
intensifi
two
addit
human
coronavirus
alreadi
circul
human
popul
identifi
caus
agent
sever
case
pneumonia
bronchiol
furthermor
novel
coronaviru
infect
human
middl
east
respiratori
syndrom
coronaviru
merscov
appear
saudi
arabia
dissemin
nine
addit
countri
date
case
merscov
report
led
fatal
http
wwwwhoint
clinic
present
infect
individu
involv
acut
pneumonia
sometim
accompani
renal
diseas
cov
similar
sarscov
merscov
also
isol
bat
wide
distribut
throughout
world
repres
potenti
reservoir
outbreak
novel
zoonos
human
therefor
understand
virul
mechan
pathogen
allow
develop
effect
therapi
order
prevent
control
futur
outbreak
sarscov
envelop
viru
contain
posit
sens
rna
genom
kb
one
largest
viral
rna
genom
known
genom
encod
viral
replicas
involv
synthesi
new
genom
gener
nest
set
subgenom
messeng
rna
encod
structur
protein
present
cov
spike
envelop
e
membran
nucleoprotein
n
group
protein
specif
sarscov
sarscov
e
protein
acid
transmembran
protein
activ
synthes
viral
infect
mainli
local
ergic
region
cell
viru
bud
morphogenesi
take
place
differ
requir
e
protein
viru
cycl
describ
among
cov
elimin
e
gene
transmiss
gastroenter
coronaviru
tgev
merscov
lead
replicationcompet
propagationdefici
phenotyp
contrast
delet
e
gene
mous
hepat
viru
mhv
sarscov
abolish
viru
product
although
viral
titer
significantli
reduc
respect
interestingli
e
gene
delet
sarscov
attenu
three
anim
model
confer
protect
challeng
parent
viru
immun
hamster
young
age
mice
repres
promis
vaccin
candid
cell
infect
show
increas
stress
apoptot
marker
compar
wild
type
viru
perhap
result
decreas
product
infect
addit
elimin
e
gene
diminish
inflamm
induc
sarscov
pathway
remark
sarscov
e
protein
found
selfinteract
form
pentamer
structur
delimit
ion
conduct
pore
may
play
role
virushost
interact
e
protein
ion
conduct
also
confirm
set
cov
differ
genera
ion
channel
ic
activ
sarscov
e
protein
map
within
transmembran
domain
protein
use
synthet
peptid
recent
studi
determin
ion
conduct
select
e
protein
ion
channel
highli
control
charg
lipid
membran
pore
assembl
suggest
lipid
headgroup
compon
channel
structur
face
lumen
pore
novel
concept
cov
e
protein
ion
channel
chemic
synthes
sarscov
e
protein
show
slight
prefer
cation
anion
reconstitut
lipid
mimick
charg
composit
ergic
membran
display
specif
select
particular
cation
addit
point
mutat
suppress
sarscov
e
protein
ic
activ
identifi
confirm
sever
report
analyz
relev
cov
e
protein
transmembran
domain
contain
ionconduct
properti
viru
matur
product
insert
alanin
residu
within
transmembran
domain
mhv
e
protein
render
crippl
virus
evolutionari
revert
restor
proper
structur
alpha
helix
within
transmembran
domain
interchang
genu
cov
mhv
e
protein
transmembran
domain
cov
differ
genera
reveal
domain
belong
genu
function
replac
mhv
e
transmembran
domain
term
viral
product
specul
effect
consequ
possibl
differ
ion
select
domain
replac
genu
cov
infecti
bronchiti
viru
ibv
e
protein
transmembran
domain
display
ic
activ
vesicular
stomat
viru
vsv
g
protein
transmembran
domain
lack
function
interf
effici
traffick
releas
viral
progeni
infect
cell
contrast
mutat
threonin
posit
alanin
amino
acid
chang
predict
inhibit
ic
activ
ibv
e
protein
affect
viruslik
particl
format
suggest
multifunct
role
e
protein
besid
e
protein
sarscov
encod
two
ionconduct
protein
relat
viru
human
coronaviru
novel
ic
activ
describ
within
protein
abund
conserv
ic
activ
suggest
import
influenc
ion
homeostasi
within
cell
cov
infect
cycl
modul
cellular
ion
balanc
seem
common
issu
virus
grow
list
viroporin
identifi
especi
within
rna
virus
highli
pathogen
human
virus
influenza
viru
human
immunodefici
viru
hiv
hepat
c
viru
hcv
sever
picornavirus
among
other
encod
least
one
viroporin
viroporin
involv
viru
entri
traffick
morphogenesi
matur
even
virul
influenza
viru
essenti
viral
rna
releas
infect
virion
within
endosom
cell
cytoplasm
also
rais
ph
transgolgi
network
lumen
prevent
prematur
activ
hemaglutinin
may
render
noninfecti
virion
similarli
hcv
protein
equilibr
ph
golgi
apparatu
protect
acidsensit
intracellular
virion
coxsackieviru
protein
alter
golgi
endoplasm
reticulum
er
h
concentr
turn
delay
protein
transport
secretori
pathway
facilit
viru
assembl
prevent
major
histocompat
complex
mhc
molecul
reach
cell
surfac
recent
find
describ
influenza
protein
ic
activ
trigger
nodlik
receptor
famili
pyrin
domain
contain
inflammasom
activ
furthermor
mutant
version
protein
conduct
na
k
ion
apart
h
ion
strongli
elicit
inflammasom
respons
novel
mechan
immun
system
activ
also
proven
viroporin
viral
protein
ic
activ
impact
differ
aspect
viru
life
cycl
howev
involv
ic
activ
pathogenesi
remain
explor
previou
find
demonstr
sarscov
e
protein
virul
determin
manuscript
analyz
contribut
e
protein
ic
activ
pathogenesi
two
recombin
virus
one
contain
singl
point
mutat
suppress
ic
activ
gener
revers
genet
mutant
virus
show
tendenc
evolv
restor
e
protein
ic
architectur
activ
serial
infect
virus
defici
ic
activ
outcompet
display
function
coinfect
highlight
import
ic
activ
viru
fit
interestingli
infect
mice
set
virus
lack
display
e
protein
ic
activ
reveal
activ
inflammasom
pathway
exacerb
inflammatori
respons
induc
sarscov
decreas
infect
channel
defici
virus
addit
less
lung
damag
proper
local
nak
atpas
within
epithelia
prevent
edema
accumul
detect
mice
infect
virus
lack
e
protein
ic
activ
consequ
increas
surviv
infect
anim
observ
e
protein
ion
conduct
absent
therefor
e
protein
ic
activ
requir
inflammasom
activ
novel
determin
virul
highli
pathogen
sarscov
delet
sarscov
e
gene
result
viru
attenu
three
anim
model
previous
shown
e
gene
code
small
multifunct
e
protein
display
ic
activ
specif
test
relev
ic
activ
viru
virul
residu
involv
e
protein
ion
conduct
firstli
identifi
end
set
synthet
peptid
repres
transmembran
domain
e
protein
evalu
ic
activ
peptid
contain
point
mutat
affect
differ
conserv
residu
residu
predict
face
lumen
channel
pore
mutat
within
transmembran
domain
e
protein
complet
disrupt
ic
activ
accordingli
two
recombin
virus
contain
two
chang
e
gene
engin
fig
sarscov
mous
adapt
genet
background
use
gener
virus
infect
mice
sarscov
accur
reproduc
symptom
human
diseas
mutant
virus
effici
rescu
clone
three
round
plaqu
purif
sequenc
confirm
data
shown
test
whether
introduc
mutat
may
alter
e
protein
subcellular
local
affect
function
protein
vero
cell
infect
wt
viru
virus
lack
ic
activ
viru
miss
e
gene
control
immunofluoresc
analysi
show
similar
coloc
pattern
e
protein
ergic
subcellular
compart
e
protein
mainli
accumul
infect
wt
mutant
virus
fig
indic
function
e
protein
associ
local
like
affect
delet
mutat
within
e
gene
sever
cov
sometim
led
crippl
virus
lower
viru
yield
test
whether
inhibit
e
protein
ic
activ
affect
viru
product
growth
kinet
perform
monkey
vero
mous
cell
minor
differ
growth
rate
observ
parent
viru
wt
contain
e
protein
ic
activ
mutant
virus
lack
e
protein
ic
activ
fig
indic
function
essenti
viru
growth
cell
cultur
strike
differ
plaqu
phenotyp
observ
mutant
virus
lack
e
protein
ic
activ
appar
form
smaller
plaqu
wt
viru
viru
plaqu
smaller
viru
fig
possibl
explan
data
could
infect
foci
product
area
may
quit
similar
regardless
e
protein
ic
activ
determin
viral
titrat
higher
cytopath
effect
may
induc
e
protein
ic
present
render
bigger
plaqu
elimin
fulllength
e
protein
induc
sever
growth
defect
fig
fig
suggest
function
protein
contribut
viru
product
apart
ic
activ
may
affect
inhibit
e
protein
ic
activ
slightli
reduc
viru
product
cell
cultur
rel
short
period
time
differ
signific
explor
whether
ion
conduct
could
improv
viral
growth
fit
longterm
competit
assay
perform
wt
viru
mutant
lack
ic
activ
rel
stabl
passag
describ
vero
cell
coinfect
mutant
wt
viru
proport
supernat
serial
passag
time
everi
hour
e
gene
sequenc
everi
passag
reveal
proport
wt
viru
steadili
increas
passag
accompani
decreas
abund
mutant
passag
wt
viru
took
maintain
major
mutant
fig
result
suggest
e
protein
ic
activ
sarscov
confer
select
advantag
improv
viru
product
specif
analyz
contribut
e
protein
ic
activ
sarscov
virul
balbc
mice
intranas
inocul
wt
viru
display
e
protein
ic
activ
three
independentlyisol
clone
mutant
virus
lack
e
protein
ic
activ
mice
monitor
daili
day
n
clone
infect
anim
show
diseas
symptom
day
post
infect
dpi
reflect
slower
movement
ruffl
fur
data
shown
mice
infect
wt
viru
start
lose
weight
day
day
die
fig
interestingli
although
mice
infect
three
clone
mutant
start
lose
weight
similar
fashion
day
almost
start
regain
weight
recov
diseas
surviv
fig
contrast
mice
infect
viru
experi
similar
weight
loss
surviv
rate
wt
viru
fig
possibl
explan
appar
discrep
revers
introduc
mutat
incorpor
compensatori
mutat
restor
e
protein
ic
activ
test
whether
case
total
rna
collect
lung
infect
mice
dpi
lung
mice
die
infect
viru
genom
region
contain
e
gene
sequenc
target
point
mutat
inhibit
ic
activ
therefor
like
place
incorpor
compensatori
mutat
e
gene
wt
viru
mutant
viru
remain
stabl
cours
experi
sinc
chang
found
viral
rna
extract
either
lung
sever
mice
dpi
dead
mice
fig
contrast
virus
incorpor
mutat
e
gene
led
amino
acid
chang
either
posit
mutat
abolish
ic
activ
rel
close
posit
within
e
protein
transmembran
domain
fig
evolv
variant
viru
appear
earli
day
mice
infect
case
mutant
complet
overgrew
origin
viru
day
tent
compensatori
mutat
also
present
viral
popul
dpi
dead
mice
fig
overal
data
obtain
wt
virus
genet
stabl
throughout
experi
suggest
e
protein
ic
activ
requir
virul
phenotyp
analyz
evolut
mutant
virus
lack
e
protein
ic
activ
two
clone
mutant
serial
passag
cell
cultur
throughout
serial
passag
e
gene
sequenc
passag
two
mutant
virus
wt
control
observ
vivo
infect
wt
viru
remain
stabl
passag
fig
virus
rapidli
incorpor
addit
mutat
within
e
gene
reproduc
vivo
observ
virus
incorpor
mutat
complet
outcompet
origin
mutant
passag
fig
contrast
virus
either
remain
stabl
incorpor
mutat
e
gene
appear
late
passag
suggest
mutant
stabl
confirm
vivo
result
fig
data
obtain
cell
cultur
mice
infect
indic
sarscov
lack
e
protein
ic
activ
incorpor
mutat
e
gene
directli
revert
origin
mutat
suppress
ic
activ
modifi
residu
map
close
posit
e
protein
transmembran
domain
modifi
residu
face
origin
mutat
inhibit
ic
activ
ion
channel
assembl
fig
analyz
whether
mutat
restor
ic
activ
synthet
peptid
repres
e
protein
transmembran
domain
contain
mutat
obtain
viral
evolut
vivo
cell
cultur
synthes
ic
activ
peptid
evalu
artifici
lipid
membran
previous
describ
wherea
peptid
contain
origin
mutat
show
conduct
peptid
contain
mutat
obtain
viral
evolut
display
similar
conduct
valu
wild
type
peptid
fig
indic
compensatori
mutat
restor
e
protein
ic
activ
correl
ic
activ
virul
found
vivo
virus
lack
ic
activ
attenu
compar
wt
viru
compet
ic
activ
mutant
viru
origin
lack
ion
conduct
rapidli
incorpor
compensatori
mutat
upon
infect
vivo
restor
ic
activ
thu
caus
pathogen
test
whether
recoveri
ic
activ
uniqu
determin
virul
rule
effect
mutat
aris
outsid
e
gene
recombin
virus
contain
set
compensatori
mutat
restor
ic
activ
rsarscoveicrev
engin
rescu
test
mice
virus
virul
mice
term
weight
loss
surviv
rate
caus
similar
diseas
caus
wt
viru
fig
sought
confirm
data
anoth
genet
background
recombin
sarscov
contain
mutat
restor
ic
activ
mutant
cell
cultur
passag
engin
evalu
agreement
revert
mutant
induc
similar
morbid
mortal
wt
fig
confirm
e
protein
ic
activ
determin
viru
pathogenesi
although
e
protein
ic
activ
essenti
viru
growth
cell
cultur
fig
possibl
product
viru
vivo
depend
ion
conduct
test
attenu
observ
vivo
ic
inact
virus
due
lower
viru
product
weekold
balbc
mice
intranas
inocul
wt
viru
genet
engin
revert
virus
display
ic
activ
mutant
lack
ic
activ
mice
lung
collect
day
post
infect
homogen
viral
titer
determin
interestingli
viru
lack
ic
activ
grew
extent
even
better
wt
revert
virus
respect
reach
titer
higher
pfugr
lung
tissu
dpi
respect
fig
data
indic
e
protein
ic
activ
significantli
affect
viru
product
vivo
experiment
condit
therefor
attenu
viru
lack
ic
activ
like
due
hostspecif
effect
mediat
ion
channel
mous
reduct
viru
yield
analyz
mechan
ic
inact
confer
less
virul
lung
section
mockinfect
mice
infect
wt
viru
ic
revert
mutant
collect
dpi
stain
hematoxylin
eosin
examin
histopatholog
chang
mockinfect
anim
show
wide
free
alveolar
bronchiolar
airway
evid
leukocyt
infiltr
fig
anim
infect
virus
display
ic
activ
present
swollen
alveoli
wall
leukocyt
infiltr
infect
area
time
point
fig
histopatholog
caus
ic
profici
virus
even
dramat
dpi
cell
infiltr
abund
air
space
collaps
profus
lung
edema
ultim
caus
acut
respiratori
distress
syndrom
ard
lead
lung
failur
death
fig
edema
accumul
dpi
also
reflect
mark
increas
fold
weight
lung
anim
infect
virus
compet
e
protein
ion
conduct
fig
contrast
mice
infect
viru
lack
ic
activ
show
moder
swollen
lung
epithelia
lung
infiltr
reflect
product
viral
infect
howev
lung
airway
remain
free
pulmonari
edema
reflect
lung
section
minim
chang
lung
weight
fig
moder
chang
lung
may
retain
effici
oxygen
exchang
data
suggest
e
protein
ic
activ
contribut
sarscov
induc
lung
edema
ard
caus
sarscov
infect
origin
accumul
protein
rich
edema
lead
sever
hypoxemia
eventu
death
lung
epitheli
cell
creat
osmot
gradient
airway
lung
interstitium
control
water
level
within
air
space
damag
epithelium
therefor
major
caus
edema
accumul
test
correl
presenc
e
protein
ic
activ
increas
epitheli
damag
lead
edema
accumul
lung
mockinfect
mice
infect
wt
viru
process
dpi
immunofluoresc
epithelium
integr
evalu
use
specif
antibodi
nak
atpas
key
factor
establish
osmot
gradient
necessari
edema
clearanc
infect
track
use
antibodi
specif
n
protein
dpi
mani
infect
cell
around
observ
lung
mice
infect
either
wt
viru
fig
overlap
product
time
viral
infect
virus
present
similar
cell
tropism
within
lung
infect
bronchiolar
epithelium
cell
alveolar
epithelium
around
cell
fig
viral
infect
caus
cell
death
lead
desquam
especi
bronchiolar
barrier
fig
dpi
number
infect
cell
dramat
reduc
close
fig
accompani
viral
titer
decreas
interestingli
wt
infect
mice
show
abund
epithelia
disassembl
time
point
especi
bronchiol
nak
atpas
misloc
basolater
posit
within
plasma
membran
epitheli
cell
consequ
bronchiolar
barrier
destruct
detect
desquam
cell
cell
debri
present
air
space
fig
edema
accumul
also
observ
fig
remov
nak
atpas
nativ
posit
within
epitheli
barrier
like
prevent
function
edema
clearanc
contrast
anim
infect
mutant
present
less
damag
epithelia
nak
atpas
locat
disturb
fig
may
allow
edema
resolut
accumul
protein
rich
edema
observ
condit
fig
sever
damag
caus
epitheli
barrier
associ
acut
inflammatori
respons
lung
parenchyma
along
edema
accumul
elev
level
inflammatori
cytokin
tnf
found
lung
ard
patient
play
key
role
progress
diseas
earli
respons
highli
inflammatori
cytokin
tightli
regul
viral
infect
recognit
pathogen
molecular
associ
pattern
pamp
cell
doubl
strand
viral
rna
induc
mrna
express
translat
gener
inact
form
protein
upon
certain
stimuli
cleav
inflammasom
activ
gener
activ
form
subsequ
secret
exert
function
interestingli
viral
protein
ic
activ
recent
found
activ
inflammasom
final
lead
secret
activ
extracellular
media
thu
sought
test
whether
e
protein
ic
activ
implic
product
activ
lung
sarscov
infect
mice
first
express
mrna
amount
deriv
protein
inact
measur
wt
mice
infect
wt
mutant
virus
induc
similar
overexpress
mrna
compar
mockinfect
anim
fig
increas
level
mrna
found
infect
mice
correl
enhanc
amount
inact
reach
similar
valu
wt
infect
fig
analyz
level
activ
secret
bronchoalveolar
lavag
perform
dpi
amount
airway
significantli
higher
mice
infect
wt
viru
display
e
protein
ic
activ
infect
mutant
miss
function
fig
collect
data
indic
e
protein
ic
activ
promot
secret
matur
without
increas
transcript
synthesi
enhanc
product
tnf
anoth
key
earli
respons
cytokin
follow
sustain
increas
time
therefor
surpris
tnf
level
dramat
increas
wtinfect
mice
comparison
mice
dpi
fig
furthermor
analysi
level
bronchoalveolar
lavag
infect
mice
dpi
reveal
overwhelm
amount
cytokin
exceed
pgml
accumul
wtinfect
mice
wherea
level
least
lower
e
protein
ic
activ
absent
infect
fig
result
indic
presenc
e
protein
ic
activ
correl
activ
inflammasom
acut
inflammatori
respons
deleteri
lung
tissu
sever
virus
caus
sever
diseas
human
encod
small
transmembran
protein
contain
ic
activ
alter
host
cell
ion
balanc
protein
usual
necessari
viru
product
matur
effect
ic
activ
pathogenesi
less
well
understood
coronavirus
caus
agent
recent
like
futur
seriou
diseas
focus
studi
sarscov
e
protein
virul
determin
display
ic
activ
manuscript
sought
elucid
role
e
protein
ic
activ
viru
pathogenesi
combin
knowledg
residu
essenti
e
protein
ion
conduct
manipul
sarscov
genom
end
use
mous
adapt
genet
background
assembl
bacteri
artifici
chromosom
bac
two
rsarscov
one
contain
mutat
transmembran
domain
e
protein
gener
knock
ic
activ
upon
competit
sever
passag
virus
lack
e
protein
ic
activ
clearli
overgrown
parent
viru
replic
better
nevertheless
differ
viral
growth
need
sever
replic
cycl
amplifi
detect
slight
signific
chang
viru
product
observ
hour
growth
kinet
agreement
result
mutat
introduc
within
ibv
e
protein
repres
equival
mutat
sarscov
e
protein
alter
product
viru
like
particl
vlp
detect
hour
fact
deeper
alter
cov
e
protein
transmembran
domain
caus
much
dramat
effect
viru
product
may
due
addit
structur
function
chang
e
protein
besid
effect
ion
conduct
conclus
e
protein
ic
activ
although
essenti
viru
product
confer
advantag
viru
enhanc
fit
growth
accordingli
select
advantag
ic
activ
also
shown
influenza
viru
mutant
lack
protein
ic
activ
overgrown
parent
viru
competit
assay
even
faster
manner
sarscov
probabl
influenza
viru
lack
ic
activ
profound
replic
defect
sarscov
encod
two
protein
also
contain
ic
properti
therefor
essenti
contribut
ic
activ
viru
product
formal
exclud
sarscov
deriv
ion
channel
could
function
compens
absenc
e
protein
ic
activ
sarscov
mutant
virus
lack
e
protein
ic
activ
show
clear
tendenc
revert
cell
cultur
vivo
mice
infect
mutant
virus
devoid
e
protein
ion
conduct
incorpor
addit
mutat
e
gene
restor
ic
activ
suggest
function
confer
select
advantag
viru
trend
evid
case
viru
evolv
quickli
frequent
mutant
viru
revers
e
protein
ic
activ
observ
mutant
mice
least
first
five
day
post
infect
attempt
sequenc
viral
progeni
day
inocul
unsuccess
probabl
viru
mostli
clear
time
point
nevertheless
mutant
restor
ion
channel
activ
long
number
passag
cell
cultur
possibl
serial
passag
vivo
mutant
could
also
revert
ion
conduct
confer
better
fit
viru
although
mutat
equal
disrupt
ic
activ
mechan
achiev
could
differ
replac
n
posit
amino
acid
predict
locat
face
channel
lumen
like
affect
channel
architectur
fact
rotat
orient
lipid
bilay
label
synthet
transmembran
peptid
bear
mutat
entir
consist
pentamer
model
contrast
mutat
impli
introduct
larger
side
chain
replac
v
f
monomermonom
interfac
like
affect
overal
structur
homooligom
therefor
inhibit
ion
conduct
caus
larger
structur
chang
may
also
explain
higher
number
compensatori
mutat
found
respect
viru
way
recov
stabl
oligom
vari
need
recov
channel
activ
compensatori
mutat
incorpor
mutant
map
opposit
face
transmembran
helix
although
adjac
e
protein
pentam
form
therefor
compensatori
mutat
like
restor
interact
assembl
mutat
monom
reinforc
hypothesi
fig
ic
activ
restor
viru
passag
suggest
function
import
viru
sever
mutat
restor
ion
channel
activ
appear
mice
cell
cultur
therefor
seem
revert
e
protein
ion
conduct
adapt
mice
main
goal
nevertheless
possibl
mutat
could
also
improv
mous
adapt
ion
channel
depend
independ
mechan
fulli
exclud
e
protein
ic
activ
also
involv
sarscov
pathogenesi
test
mous
model
virus
lack
ic
activ
stabl
multipl
passag
mutant
caus
reduc
mortal
wherea
wt
mutant
virus
restor
ic
activ
mice
infect
backgroundevolv
variant
caus
high
mortal
rate
furthermor
genet
engin
virus
contain
point
mutat
necessari
recov
e
protein
ic
activ
induc
similar
mortal
wt
viru
reinforc
e
protein
ic
activ
contribut
sarscov
pathogen
relev
viroporin
viru
virul
also
shown
virus
respiratori
syncyti
viru
sh
protein
influenza
viru
protein
classic
swine
fever
viru
protein
delet
larg
fraction
entir
protein
viroporin
may
play
critic
function
apart
ion
conduct
therefor
direct
correl
ic
activ
virul
could
formal
establish
knowledg
first
time
ic
activ
viroporin
directli
link
virul
viru
infect
highli
pathogen
respiratori
virus
includ
sarscov
one
caus
agent
acut
lung
injuri
ali
sever
form
ard
unit
state
ard
case
report
annual
mortal
rate
late
stage
ard
character
develop
pulmonari
edema
lead
impair
ga
exchang
hypoxemia
eventu
death
infect
mice
result
abund
edema
accumul
alveolar
bronchiolar
space
late
time
post
infect
dpi
correl
mortal
phenotyp
reproduc
upon
mice
infect
highlyvirul
sarscov
display
ic
activ
base
altern
e
protein
sequenc
revert
virus
side
infect
mice
attenu
mutant
lack
e
protein
ic
activ
caus
significantli
reduc
edema
accumul
like
contribut
major
anim
surviv
collect
data
indic
e
protein
ic
activ
vivo
promot
lung
patholog
edema
accumul
pulmonari
epithelia
regul
water
level
present
within
air
space
critic
paramet
ga
exchang
play
critic
role
edema
clearanc
epitheli
cell
creat
osmot
gradient
mainli
coordin
na
transport
first
airway
cell
cytoplasm
epitheli
sodium
channel
enac
locat
apic
part
plasma
membran
interstitium
nak
atpas
present
basolater
region
plasma
membran
vectori
transport
na
accompani
water
remov
airspac
edema
resolut
integr
alveolar
bronchiolar
epithelia
analyz
label
nak
atpas
lung
mice
infect
viru
contain
lack
ic
activ
interestingli
anim
infect
wt
viru
present
strong
disassembl
bronchiolar
epithelia
misloc
nak
atpas
basolater
distribut
within
cell
late
time
coincid
edema
accumul
contrast
epithelia
integr
clearli
preserv
lung
anim
infect
viru
miss
e
protein
ic
activ
intact
lung
epithelia
may
requir
proper
function
main
compon
involv
edema
resolut
nak
atpas
enac
may
explain
lack
edema
therefor
attenu
observ
viru
previous
describ
sarscov
differ
viral
tropism
within
lung
cell
without
affect
viral
product
induc
differ
patholog
nevertheless
observ
signific
differ
infect
pattern
presenc
absenc
e
protein
ion
channel
activ
suggest
virul
confer
e
protein
ic
activ
depend
altern
tropism
pulmonari
epithelia
damag
lead
ali
ard
consequ
cytokin
burst
initi
case
viral
infect
one
key
earlyrespons
cytokin
drive
proinflammatori
activ
bronchoalveolar
space
mainli
produc
macrophag
dendrit
cell
inflammasom
activ
ion
imbal
within
cell
describ
trigger
pathway
level
activ
secret
airway
enhanc
e
protein
ic
activ
conserv
sarscov
infect
take
account
presenc
absenc
sarscov
e
protein
ic
activ
interfer
product
precursor
mrna
protein
level
result
suggest
e
protein
ion
conduct
may
induc
inflammasom
trigger
result
secret
matur
agreement
hypothesi
releas
activ
recent
report
viroporin
virus
implic
develop
divers
patholog
includ
obes
atherosclerosi
diabet
sever
pulmonari
ill
asthma
pulmonari
obstruct
chronic
diseas
ard
progress
edema
accumul
report
implic
cytokin
sarscov
patholog
e
protein
ion
channel
activ
trigger
product
ard
progress
involv
product
tnf
anoth
earli
respons
cytokin
exert
function
sustain
manner
accumul
diseas
found
sarscov
infect
pattern
cytokin
express
clearli
reproduc
tnf
accumul
higher
level
lung
anim
infect
wt
viru
display
ic
activ
compar
mutant
lack
ion
conduct
enhanc
product
tnf
stimul
cytokin
provid
integr
amplifi
inflammatori
respons
detriment
pulmonari
function
elev
amount
cytokin
report
bronchoalveolar
lavag
sarscov
patient
therefor
enhanc
amount
activ
found
anim
infect
wt
viru
may
explain
increas
level
tnf
lead
sever
patholog
import
note
increas
damag
found
pulmonari
epithelia
infect
viru
display
e
protein
ic
activ
may
explain
higher
viru
product
suppress
e
protein
ic
activ
render
similar
growth
mice
lung
analyz
time
point
sarscov
earli
replic
may
relev
issu
induct
patholog
exclud
earli
replic
defect
mutant
mice
delay
viru
growth
first
hour
postinfect
nevertheless
altern
explan
also
possibl
describ
mutat
sarscov
gene
confer
increas
virul
without
affect
growth
within
mice
even
earli
time
increas
pathogenesi
mainli
depend
exacerb
host
respons
viral
infect
accordingli
enhanc
inflammatori
respons
trigger
e
protein
ion
channel
profici
virus
may
major
patholog
induc
studi
shown
sarscov
e
protein
ic
activ
virul
determin
influenc
inflammatori
respons
includ
inflammasomederiv
pulmonari
damag
diseas
outcom
although
essenti
viru
product
e
protein
ic
activ
confer
select
advantag
parent
viru
compet
ion
conduct
fit
nevertheless
virul
associ
e
protein
ion
conduct
could
repres
nonselect
consequ
sarscov
cross
speci
barrier
zoonot
reservoir
bat
palm
civet
raccoon
dog
human
caus
sever
diseas
possibl
sarscov
infect
natur
host
e
protein
ion
channel
activ
may
relev
impact
sarscov
pathogenesi
therefor
posit
select
cross
speci
barrier
conclus
work
provid
sever
find
may
translat
relev
coronavirus
highli
pathogen
merscov
even
virus
encod
protein
ic
activ
anim
experiment
protocol
approv
ethic
committe
center
anim
health
research
cisainia
permit
number
strict
accord
spanish
nation
royal
decre
rd
intern
eu
guidelin
protect
anim
use
experiment
scientif
purpos
spanish
nation
law
anim
welfar
exploit
transport
sacrific
also
accord
royal
decre
rd
infect
mice
hous
ventil
rack
allentown
nj
african
green
monkey
kidneyderiv
vero
cell
kindli
provid
eric
snijder
medic
center
univers
leiden
netherland
mous
delay
brain
tumor
cell
stabli
express
murin
receptor
sarscov
gener
previous
describ
babi
hamster
kidney
cell
obtain
american
type
cultur
collect
atcc
cell
grown
atmospher
humid
dulbecco
modifi
eagl
medium
dmem
gibco
supplement
mm
hepe
mm
lglutamin
sigma
non
essenti
amino
acid
sigma
fetal
bovin
serum
fb
biowhittak
specificpathogenfre
weekold
balbc
olahsd
femal
mice
purchas
harlan
mice
maintain
addit
week
anim
care
facil
nation
center
biotechnolog
madrid
protocol
approv
ethic
review
committe
center
anim
health
research
cisainia
infect
experi
mice
femal
anesthet
isofluran
intranas
inocul
pfu
indic
virus
work
infect
anim
perform
laboratori
cisa
inia
equip
ventil
rack
anim
transport
unitbio
contain
unit
harvard
store
anim
experi
infecti
cdna
clone
encod
mous
adapt
sarscov
assembl
bacteri
artifici
chromosom
bac
laboratori
use
background
introduc
mutat
inhibit
restor
e
protein
ic
activ
briefli
dna
fragment
repres
nucleotid
genom
flank
restrict
site
bamhi
mfei
respect
chemic
synthes
bio
basic
inc
fragment
contain
differ
point
mutat
within
e
gene
gener
amino
acid
chang
inhibit
ic
activ
aat
gcc
gta
ttc
restor
activ
gcc
gac
gta
ttc
ctt
gca
gta
ttc
ttg
tcg
gta
ttc
aca
ata
gta
ttc
ctt
cgt
fragment
contain
mutat
digest
exchang
origin
bac
genet
integr
clone
dna
verifi
restrict
analysi
sequenc
bhk
cell
grown
confluenc
flask
transfect
infecti
cdna
clone
lipofectamin
invitrogen
accord
manufactur
specif
hour
post
transfect
cell
trypsin
ad
vero
cell
confluent
monolay
grown
flask
incub
h
cell
supernat
harvest
passag
fresh
cell
recov
virus
clone
three
round
plaqu
purif
follow
standard
procedur
vero
cell
grown
confluenc
flask
infect
multipl
infect
moi
cell
supernat
collect
hpi
titrat
vero
cell
viru
titrat
plaqu
detect
supernat
infect
cell
ad
confluent
monolay
vero
cell
incub
min
media
remov
cell
overlaid
dmem
contain
low
melt
agaros
fetal
calf
serum
fc
hpi
cell
fix
formaldehyd
stain
crystal
violet
vero
cell
grown
confluenc
glass
coverslip
infect
rsarscov
wt
moi
indic
hpi
media
remov
cell
wash
twice
pb
fix
paraformaldehyd
pb
min
room
temperatur
cell
wash
twice
pb
permeabil
min
saponin
fb
pb
primari
antibodi
incub
perform
pb
contain
fb
saponin
h
min
room
temperatur
immunofluoresc
perform
use
mous
mab
specif
dilut
alexi
biochem
rabbit
pab
specif
e
protein
dilut
coverslip
wash
four
time
pb
primari
secondari
antibodi
incub
alexa
alexa
antibodi
specif
differ
speci
dilut
invitrogen
incub
min
room
temperatur
pb
contain
fb
nuclei
stain
use
dapi
dilut
sigma
coverslip
mount
prolong
gold
antifad
reagent
invitrogen
examin
leica
confoc
microscop
leica
microsystem
coloc
studi
perform
use
leica
la
af
softwar
genom
region
includ
nucleotid
contain
e
gene
sequenc
rt
pcr
reaction
briefli
total
rna
infect
cell
homogen
mice
lung
collect
purifi
use
rneasi
kit
qiagen
accord
manufactur
specif
rt
reaction
rna
use
templat
random
oligonucleotid
primer
thermoscript
revers
transcriptas
invitrogen
product
subsequ
subject
pcr
reaction
use
oligonucleotid
ev
ctcttcaggagttgctaatccagcaatgg
er
tccaggagttgtttaagctcctcaacggta
vent
polymeras
new
england
biolab
follow
manufactur
recommend
sequenc
assembl
comparison
consensu
sequenc
strain
perform
seqman
program
lasergen
madison
wi
confluent
monolay
vero
cell
grown
flask
infect
moi
virus
rsarscov
wt
hpi
supernat
collect
passag
fresh
monolay
vero
cell
perform
time
serial
e
gene
sequenc
analyz
passag
describ
vivo
experi
mice
intranas
inocul
pfu
virus
describ
lung
collect
day
post
infect
incub
rnalat
ambion
hpi
prior
freez
extract
total
rna
lung
homogen
ml
rlt
lysi
buffer
qiagen
contain
use
gentlemac
dissoci
miltenyi
biotec
sampl
centrifug
rpm
min
rna
purifi
supernat
use
rneasi
kit
qiagen
previous
describ
synthet
peptid
repres
transmembran
domain
sarscov
e
protein
amino
acid
encod
point
mutat
appear
serial
infect
mutant
virus
gener
standard
phase
synthesi
purifi
hplc
ic
activ
test
artifici
lipid
membran
previous
describ
total
rna
coinfect
cell
isol
e
gene
sequenc
describ
rel
abund
rsarscov
wt
virus
within
viral
popul
determin
quantifi
rel
amount
respect
e
gene
genet
marker
sequenc
obtain
popul
weekold
balbc
mice
femal
intranas
inocul
pfu
virus
rsarscov
wt
dmem
contain
fc
weight
loss
surviv
infect
mice
monitor
day
anim
reach
weight
loss
higher
initi
bodi
weight
sacrif
accord
establish
euthanasia
protocol
mice
inocul
pfu
viru
rsarscov
wt
sacrif
day
post
infect
lung
collect
analyz
viral
growth
right
lung
homogen
ml
phosphat
buffer
salin
pb
contain
uiml
penicillin
streptomycin
gentamicin
fungizon
use
mac
homogen
miltenyi
biotec
accord
manufactur
protocol
titer
previous
describ
examin
lung
histopatholog
left
lung
infect
mice
incub
zinc
formalin
h
embed
paraffin
section
stain
hematoxylin
eosin
five
micron
section
zinc
formalin
fix
lung
deparaffin
rehydr
success
incub
xylol
ethanol
ethanol
antigen
unmask
perform
boil
sampl
citrat
buffer
mm
sodium
citrat
mm
citric
acid
ph
min
decloak
chamber
biocar
medic
sampl
permeabil
triton
pb
min
block
bovin
serum
albumin
bsa
triton
pb
min
sampl
label
mous
monoclon
antibodi
specif
sarscov
n
protein
kindli
provid
ying
fang
south
dakota
state
univers
dilut
rabbit
monoclon
antibodi
specif
nak
atpas
alpha
subunit
abcam
dilut
triton
bsa
pb
h
min
room
temperatur
goat
antimous
goat
antirabbit
secondari
antibodi
bound
alexa
alexa
fluorophor
use
respect
dilut
triton
bsa
pb
min
room
temperatur
cell
nuclei
stain
dapi
tissu
mount
prolong
antifad
reagent
invitrogen
analyz
leica
tc
confoc
microscop
rna
extract
lung
infect
mice
prepar
describ
subject
retro
transcriptas
reaction
use
highcapac
cdna
transcript
kit
appli
biosystem
gener
cdna
pcr
use
taqman
assay
specif
ribosom
rna
control
appli
biosystem
perform
data
acquir
abi
prism
sequenc
detect
system
appli
biosystem
analyz
use
abi
prism
sd
softwar
gene
express
rel
mockinfect
sampl
shown
lung
infect
mice
collect
dpi
right
lung
homogen
ml
protein
lysi
buffer
contain
trishcl
mm
edta
mm
nacl
mm
igep
complet
proteas
inhibitor
roch
use
mac
homogen
miltenyi
biotec
sampl
centrifug
h
g
supernat
collect
level
analyz
western
blot
use
goat
anti
mous
antibodi
r
system
load
control
betaactin
label
use
mous
monoclon
antibodi
abcam
bound
antibodi
detect
use
rabbit
anti
goat
rabbit
anti
mous
hrp
conjug
antibodi
immobilon
western
chemiluminisc
substrat
millipor
follow
manufactur
specif
densitometr
analysi
perform
nonsatur
exposur
sever
experiment
replic
use
quantiti
one
version
softwar
biorad
level
normal
level
betaactin
follow
euthanasia
cervic
disloc
trachea
expos
cannul
anim
mouth
gaug
tube
lung
lavag
three
time
cold
phosphat
buffer
salin
pb
sampl
centrifug
minut
g
separ
cellular
content
supernat
collect
analyz
cytokin
level
bronchoalveolar
lavag
treat
igep
reach
final
concentr
inactiv
sampl
infect
express
tnf
measur
use
luminex
technolog
mous
cytokin
antibodi
bead
kit
milliplex
map
kit
millipor
accord
manufactur
specif
